Understanding Your Risk Factors and Dosing Limits

While many factors contribute to retinal health, the risk of developing toxicity from antimalarial medications is primarily driven by how much you take and for how long. Understanding your personal risk profile allows you and your doctor to tailor your screening schedule and catch any changes as early as possible.

Important: The dosages discussed below are clinical guidelines used by prescribers. They are not absolute guarantees of safety. Never change your dose or stop your medication without speaking to your prescribing doctor.

The Importance of Dosing Guidelines

The most critical risk factor is your daily dose. Modern guidelines from the American Academy of Ophthalmology (AAO) emphasize using your real (actual) body weight to calculate a recommended maximum daily dose ^[1].

• Hydroxychloroquine (Plaquenil): The recommended maximum dose is 5 mg per kilogram (mg/kg) of your actual weight per day ^[2]. For a person weighing 70kg (154 lbs), this target is 350mg per day.
• Chloroquine: This older medication is more toxic to the retina. The recommended maximum is lower, at 2.3 mg/kg of actual body weight ^[3][2].

In large observational cohorts, staying at or below these daily limits is associated with a risk of retinal damage of less than 2% during the first 10 years ^[4]. However, for those prescribed higher doses (e.g., >6 mg/kg), studies show the risk can jump past 20% by the 15-year mark ^[5]. Note: Because tablets come in set sizes (like 200mg), your doctor may prescribe an alternating schedule (e.g., one pill one day, two the next) to achieve your specific average daily target.

Duration of Use

The longer you take these medications, the more they accumulate.

• The 5-Year Milestone: For most people on a well-managed daily dose, the risk of toxicity in the first five years is very low (about 0.1%) ^[5]. After five years, the risk begins to rise more sharply, which is why annual screening usually begins ^[6].
• A Note on Cumulative Dose: Historically, reaching 1,000 grams of total lifetime exposure was used as an automatic threshold for high risk. Modern practice looks more closely at your daily dose, actual weight, and kidney function, rather than relying solely on the cumulative total ^[7][8].

Secondary Risk Factors

Some health conditions or other medications can change how your body processes antimalarials, making you more susceptible to damage:

• Chronic Kidney Disease (CKD): If your kidneys aren’t filtering waste efficiently (Stage 3 or higher, measured by GFR), the medication can stay in your system longer, effectively increasing your exposure. In some studies, this has been shown to roughly double the risk of toxicity ^[9][10].
• Tamoxifen: This medication, often used for breast cancer, has its own effects on the retina. When taken concurrently with hydroxychloroquine, it can substantially increase the risk of toxicity (more than threefold in some cohorts) ^[9].
• Age and Retinal Health: Older age (e.g., starting treatment over age 55) or having pre-existing retinal disease may also elevate risk ^[9].

The Role of Ancestry in Screening

Your genetic background can influence where the damage shows up in your eye.

• Parafoveal Damage: Often seen in Caucasian patients, this damage forms a tight ring immediately surrounding the center of vision ^[11].
• Pericentral Damage: Patients of Asian descent have a higher risk of pericentral toxicity ^[12]. This damage occurs further out from the center.

Because pericentral damage can be completely missed by standard “close-in” 10-2 vision tests, it is highly appropriate and recommended to use “wide-pattern” screening tests, such as a 30-2 or 24-2C visual field, for patients with Asian ancestry to ensure the correct areas are checked ^[13][11].